Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin. - Wikidata - thesis-toulmin - TriplyDB

Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.

Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.

http://www.wikidata.org/entity/Q33798218

about

Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 5. Oseltamivir Carboxylate Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.

P2860

Q33798554-0D6C79CE-3FBC-4577-910E-D1EAB6BC814A Q38810304-3D067D61-F9CC-4389-97CE-66A8697DABCC Q41284108-80BF2177-7A97-4736-B992-8B6D69DF4F7F Q41830402-6A63929A-1E99-41C4-BEC7-74EECF656092 Q42407634-7D4FC67F-8DCD-409C-BB47-A3F0B7E1CF7D Q53217740-1A8C1EF3-A235-4928-8FDD-72D65E0105A7

P2860

Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.

http://www.wikidata.org/entity/Q33798218

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@ast

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@en

type

label

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@ast

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@en

prefLabel

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@ast

Biopharmaceutical characteriza ...... xifloxacin, and grepafloxacin.

@en

P1433

Q33798218-E760D27B-8A4D-4B6B-A479-625E5588888F

P1476

Q33798218-1F169B83-417B-469D-A49A-C12C53BF89AD

P2093

Q33798218-2909B635-76AC-4E1F-84F9-DB970CF74B63

Q33798218-4C4FCD67-F17E-49A5-8C0A-D8A939133AC3

Q33798218-88C69126-2D48-42EC-AFB7-6987E3B531C8

P2860

Q33798218-04FFFBA6-DD55-4673-A797-C515F811D8D0

Q33798218-1A7A36DF-B4BC-45CB-91DC-11BE11D645D0

Q33798218-1BA53CB1-EAE3-4E3F-A737-7022CEBF9CFF

Q33798218-2745A929-CCAC-4AEF-8617-64659B998493

Q33798218-2A38C09C-0049-41B9-888F-10EB5D8A1B27

Q33798218-315BC081-9D18-4977-96E6-CAC986A233D1

Q33798218-31D1487F-C567-4BCB-ADD6-2A230587C05E

Q33798218-3B065321-CBB0-4234-8970-AFBD955495A7

Q33798218-43D23AFD-58CC-4D03-8C04-4B9D87BAA231

Q33798218-47F6024A-FFAF-41CF-92F6-706924C7FF94

P304

Q33798218-2AFFC61E-380A-4987-8EF4-9F1CEAA03F05

P31

Q33798218-253A0283-047A-4833-9016-D54B27A74E48

P356

Q33798218-E1B51236-2D39-46EE-BB7C-661B64E3AEBD

P407

Q33798218-94DF6FC5-729D-49C0-8C50-1130BF9F080D

P433

Q33798218-5D46A7D3-4AC7-41E1-A783-4299E3994DDA

P478

Q33798218-D5609F9F-24B4-4081-B14C-5D259D5FE662

P50

Q33798218-0DCDB6C0-7D53-4F54-A98B-7151F934F99D

Q33798218-951814A9-CEA4-451F-8CF7-50C28D49F3D8

Q33798218-DC3C4108-2A49-448D-BEFA-16EFCB956BAB

Q33798218-F52C533C-088C-4A14-A6A2-0E68582CFC51

P577

Q33798218-E95A4C1D-7207-48FA-9DF3-7592D7BAE706

P698

Q33798218-988A987D-84E4-4AC2-8166-7812449FE9E1

P932

Q33798218-395B9847-F66E-4E6E-BE4E-6D2B9E3DEFC6

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Biopharmaceutical characteriza ...... oxifloxacin, and grepafloxacin

@en

P2093

Aline Vidal Lacerda Gontijo

http://www.w3.org/2001/XMLSchema#string

Isabelle Lamarche

http://www.w3.org/2001/XMLSchema#string

Patrice Gobin

http://www.w3.org/2001/XMLSchema#string

P2860

Cell size of alveolar macrophages: an interspecies comparison

Ways to fit a PK model with some data below the quantification limit.

Application of basic pharmacokinetic concepts to analysis of microdialysis data: illustration with imipenem muscle distribution.

Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures.

Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin

Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.

Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats

Aerosolised antibiotics: a critical appraisal of their use.

P304

3942-3949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02818-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Sandrine Marchand

Nicolas Grégoire

Julien Brillault

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24798283

http://www.w3.org/2001/XMLSchema#string

P932

4068515

http://www.w3.org/2001/XMLSchema#string